Clinical applications for diffusion magnetic resonance imaging in radiotherapy.

In this article, we review the clinical applications of diffusion magnetic resonance imaging (MRI) in the radiotherapy treatment of several key clinical sites, including those of the central nervous system, the head and neck, the prostate, and the cervix. Diffusion-weighted MRI (DWI) is an imaging technique that is rapidly gaining widespread acceptance owing to its ease and wide availability. DWI measures the mobility of water within tissue at the cellular level without the need of any exogenous contrast agent. For radiotherapy treatment planning, DWI improves upon conventional imaging techniques, by better characterization of tumor tissue properties required for tumor grading, diagnosis, and target volume delineation. Because DWI is also a sensitive marker for alterations in tumor cellularity, it has potential clinical applications in the early assessment of treatment response following radiation therapy.

[1]  P. Brown,et al.  Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  A. A. Abdel Razek,et al.  Role of diffusion-weighted MR imaging in cervical lymphadenopathy , 2006, European Radiology.

[3]  D. Yousem,et al.  ADC values and prognosis of malignant astrocytomas: does lower ADC predict a worse prognosis independent of grade of tumor?--a meta-analysis. , 2013, AJR. American journal of roentgenology.

[4]  J. Gore,et al.  Theoretical Model for Water Diffusion in Tissues , 1995, Magnetic resonance in medicine.

[5]  T. Chenevert,et al.  Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck. , 2008, Translational oncology.

[6]  B. K. Park,et al.  Prostate MR imaging at 3T using a phased-arrayed coil in predicting locally recurrent prostate cancer after radiation therapy: preliminary experience , 2010, Abdominal Imaging.

[7]  Yue Cao,et al.  Radiation-induced changes in normal-appearing white matter in patients with cerebral tumors: a diffusion tensor imaging study. , 2008, International journal of radiation oncology, biology, physics.

[8]  Chaya S Moskowitz,et al.  Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy? , 2013, Radiology.

[9]  E. M. Pedersen,et al.  Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer , 2010, Acta oncologica.

[10]  J. M. Taylor,et al.  Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. , 2000, Journal of the National Cancer Institute.

[11]  Yue Cao,et al.  Investigation of the diffusion abnormality index as a new imaging biomarker for early assessment of brain tumor response to radiation therapy. , 2014, Neuro-oncology.

[12]  Chuan-miao Xie,et al.  Diffusion-Weighted Magnetic Resonance Imaging for Prediction of Response of Advanced Cervical Cancer to Chemoradiation , 2011, Journal of computer assisted tomography.

[13]  Bradford A Moffat,et al.  Therapeutic Efficacy of DTI-015 using Diffusion Magnetic Resonance Imaging as an Early Surrogate Marker , 2004, Clinical Cancer Research.

[14]  Thomas L. Chenevert Principles of Diffusion-Weighted Imaging (DW-MRI) as Applied to Body Imaging , 2010 .

[15]  J G Pipe,et al.  Effect of bulk tissue motion on quantitative perfusion and diffusion magnetic resonance imaging , 1991, Magnetic resonance in medicine.

[16]  T L Chenevert,et al.  Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  A. Peiffer,et al.  Imaging Radiation-Induced Normal Tissue Injury , 2012, Radiation research.

[18]  Ernst J Rummeny,et al.  Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. , 2009, European journal of radiology.

[19]  Sandra Nuyts,et al.  Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. , 2009, Radiology.

[20]  Risto A Kauppinen,et al.  Monitoring cytotoxic tumour treatment response by diffusion magnetic resonance imaging and proton spectroscopy , 2002, NMR in biomedicine.

[21]  D. Norris Implications of bulk motion for diffusion‐weighted imaging experiments: Effects, mechanisms, and solutions , 2001, Journal of magnetic resonance imaging : JMRI.

[22]  P. Narayana,et al.  Serial diffusion tensor imaging to characterize radiation-induced changes in normal-appearing white matter following radiotherapy in patients with adult low-grade gliomas , 2008, Radiation Medicine.

[23]  C. Kim,et al.  Prediction of locally recurrent prostate cancer after radiation therapy: Incremental value of 3T diffusion‐weighted MRI , 2009, Journal of magnetic resonance imaging : JMRI.

[24]  Zhibin Huang,et al.  Longitudinal changes in tumor perfusion pattern during the radiation therapy course and its clinical impact in cervical cancer. , 2010, International journal of radiation oncology, biology, physics.

[25]  Jian Z. Wang,et al.  Characterizing tumor heterogeneity with functional imaging and quantifying high-risk tumor volume for early prediction of treatment outcome: cervical cancer as a model. , 2012, International Journal of Radiation Oncology, Biology, Physics.

[26]  D. Norris The effects of microscopic tissue parameters on the diffusion weighted magnetic resonance imaging experiment , 2001, NMR in biomedicine.

[27]  Fiona J. Gilbert,et al.  Early diffusion weighted magnetic resonance imaging can predict survival in women with locally advanced cancer of the cervix treated with combined chemo-radiation , 2012, European Radiology.

[28]  Bradford A Moffat,et al.  A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. , 2009, Translational oncology.

[29]  Bradford A Moffat,et al.  Evaluation of cancer therapy using diffusion magnetic resonance imaging. , 2003, Molecular cancer therapeutics.

[30]  C. Pelizzari,et al.  Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging. , 2013, International journal of radiation oncology, biology, physics.

[31]  Shiro Baba,et al.  Diffusion-weighted imaging of local recurrent prostate cancer after radiation therapy: comparison with 22-core three-dimensional prostate mapping biopsy. , 2012, Magnetic resonance imaging.

[32]  Timothy D Johnson,et al.  Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  C. Meyer,et al.  Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[34]  P. Grigsby,et al.  Tumor volume and subvolume concordance between FDG‐PET/CT and diffusion‐weighted MRI for squamous cell carcinoma of the cervix , 2013, Journal of magnetic resonance imaging : JMRI.

[35]  D. Le Bihan,et al.  Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. , 1988, Radiology.

[36]  Bradford A Moffat,et al.  Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Jacob Sosna,et al.  MR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla. , 2004, Academic radiology.

[38]  Takeo Ishigaki,et al.  Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. , 2007, European journal of radiology.

[39]  Tobias Fechter,et al.  3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer – an interobserver variability study , 2013, Radiation oncology.

[40]  Timothy D Johnson,et al.  Comparison of apparent diffusion coefficients and distributed diffusion coefficients in high‐grade gliomas , 2010, Journal of magnetic resonance imaging : JMRI.

[41]  Timothy D Johnson,et al.  The parametric response map is an imaging biomarker for early cancer treatment outcome , 2009, Nature Medicine.

[42]  Daniel E. Hall,et al.  Molecular imaging of gene expression and efficacy following adenoviral-mediated brain tumor gene therapy. , 2002, Molecular imaging.

[43]  H. Buchtel,et al.  Diffusion tensor imaging of normal-appearing white matter as biomarker for radiation-induced late delayed cognitive decline. , 2012, International journal of radiation oncology, biology, physics.

[44]  Lawrence H. Schwartz,et al.  Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results , 2011, European Radiology.

[45]  Aytekin Oto,et al.  Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. , 2010, Radiology.

[46]  Toshinori Hirai,et al.  Usefulness of diffusion-weighted imaging in the localization of prostate cancer. , 2009, International journal of radiation oncology, biology, physics.

[47]  H. Lanfermann,et al.  Cerebral gliomas: diffusional kurtosis imaging analysis of microstructural differences. , 2010, Radiology.

[48]  Jason A Koutcher,et al.  Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. , 2009, Radiology.

[49]  David A Jaffray,et al.  Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancer , 2013, Journal of magnetic resonance imaging : JMRI.

[50]  F. Gilbert,et al.  Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. , 2008, Gynecologic oncology.

[51]  Timothy D Johnson,et al.  Prospective Analysis of Parametric Response Map–Derived MRI Biomarkers: Identification of Early and Distinct Glioma Response Patterns Not Predicted by Standard Radiographic Assessment , 2011, Clinical Cancer Research.

[52]  P. Grenier,et al.  MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. , 1986, Radiology.

[53]  F. Mottaghy,et al.  Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules? , 2012, International journal of radiation oncology, biology, physics.

[54]  Masoom A. Haider,et al.  Diffusion-weighted MRI in cervical cancer , 2008, European Radiology.

[55]  Jan Sijbers,et al.  Gliomas: diffusion kurtosis MR imaging in grading. , 2012, Radiology.

[56]  D. Moody,et al.  Vascular Damage after Fractionated Whole-Brain Irradiation in Rats , 2005, Radiation research.

[57]  Toshinori Hirai,et al.  Usefulness of diffusion‐weighted MRI with echo‐planar technique in the evaluation of cellularity in gliomas , 1999, Journal of magnetic resonance imaging : JMRI.